A survey on adherence to secondary ischemic stroke prevention
- 1 January 2006
- journal article
- research article
- Published by Taylor & Francis in Neurological Research
- Vol. 28 (1) , 16-20
- https://doi.org/10.1179/016164106x91816
Abstract
Reduced adherence and compliance to discharge instructions and protocols could significantly influence the ability of any stroke prevention strategy. The goals of this investigation were to evaluate the adherence to secondary prevention strategies within 1 year after ischemic stroke and to identify possible causes of poor compliance with these strategies. Patients who had suffered either acute ischemic stroke or transient ischemic attacks (TIA) were recruited retrospectively through telephone follow-up. The survey included whether the patient was prescribed antithrombotic treatment at discharge and reasons for non-compliance with this prescription both immediately after discharge and 1 year after discharge. Of 472 (73.8%) patients with detailed clinical data who were finally evaluated in this survey, 326 (69.1%) were still under antithrombotic treatment and 172 (36.4%) underwent the same antithrombotic agent as prescribed when discharged. We found that medical insurance and free medical care were able to promote compliance with medication in stroke patients for secondary prevention, while administration of non-aspirin antithrombotic agents or a poor ability for daily activities (Barthel index, BI) had significantly negative effects on medication compliance in stroke patients. Under the conditions of this observational study, adherence to stroke prevention strategies was poor. Income levels, categories of antithrombotic agents and the personal living ability are closely related to compliance. The results suggest that doctors should pay more attention to the secondary prevention of stroke. We suggest that providing stroke patients with detailed instructions for medication usage, physicians could increase the potential that their secondary prevention of stroke could be increased.Keywords
This publication has 13 references indexed in Scilit:
- Secondary prevention for stroke in the United Kingdom: results from the National Sentinel Audit of StrokeAge and Ageing, 2004
- Attrition and Non-Compliance in Secondary Stroke Prevention TrialsNeuroepidemiology, 2004
- Adherence to Secondary Stroke Prevention Strategies – Results from the German Stroke Data BankCerebrovascular Diseases, 2003
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summaryJournal of the American College of Cardiology, 2001
- Compliance With Secondary Prevention of Ischemic StrokeStroke, 2001
- Stroke preventionNeurology, 2000
- A Metaregression Analysis of the Dose-Response Effect of Aspirin on StrokeArchives of internal medicine (1960), 1999
- Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trialThe Lancet, 1996
- Optimal Oral Anticoagulant Therapy in Patients with Nonrheumatic Atrial Fibrillation and Recent Cerebral IschemiaNew England Journal of Medicine, 1995